-
2023-510465-10-00
4
2025-03-10
Meningococcal immunization
-
2024-510753-10-00
5
2024-11-01
Prurigo Nodularis
-
2023-504753-12-00
5
2024-10-01
Lung Cancer, Non-Small Cell
-
2023-505892-56-00
5
2024-09-30
Major Depressive Disorder
-
2022-502640-12-01
9
2024-09-27
Non-small cell lung cancer (NSCLC)
-
2023-509762-38-00
5
2024-08-01
Respiratory Syncytial Virus Infections
-
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
-
2023-506335-15-00
5
2024-07-18
Major Depressive Disorder
-
2023-505023-31-00
5
2023-11-17
Renal cell carcinoma
-
2022-503004-24-00
5
2023-10-20
Influenza virus
-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
-
2022-500100-21-01
4
2023-09-11
Follicular lymphoma
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2023-505057-40-00
4
2022-12-02
Lung Cancer, Non-Small Cell
-
2023-505579-53-00
5
2022-10-25
Diffuse large B-cell lymphoma (DLBCL)
-
2023-506929-11-00
5
2022-10-17
Overweight and obesity
-
2023-508265-33-00
5
2022-10-13
Vasomotor symptoms caused by adjuvant endocrine therapy in women with,
-
2023-510145-25-00
5
2022-08-23
Meningococcal infection
-
2023-505255-51-00
5
2022-08-08
Herpes Zoster
-
2024-510800-35-00
5
2022-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-508897-27-00
5
2022-04-28
Multiple Myeloma
-
2023-503517-30-00
5
2022-04-01
Extensive-stage small-cell lung cancer
-
2023-509864-96-00
4
2021-12-07
Mantle Cell Lymphoma (MCL)
-
2023-509208-14-00
5
2021-09-28
MULTIPLE MYELOMA